Post-CAR T Cell Therapy Lymphoproliferative Disorders Explained
Chimeric antigen receptor (CAR) T cell therapy is revolutionizing the treatment landscape of hematological malignancies, presenting a potent, targeted immunotherapeutic...
Nathaniel Bowman is a Scienmag editorial specialist profile for Precision Oncology coverage.
Chimeric antigen receptor (CAR) T cell therapy is revolutionizing the treatment landscape of hematological malignancies, presenting a potent, targeted immunotherapeutic...
In the relentless battle against breast cancer, one of the most formidable obstacles remains endocrine resistance, particularly within hormone receptor–positive...
In a groundbreaking study recently published in Nature Communications, researchers from the Institute for Systems Biology (ISB) have shed new...
In a groundbreaking study poised to reshape the future of dermatological care, researchers from the University of Gothenburg and Chalmers...
In an extraordinary breakthrough, researchers have unveiled critical insights into the enigmatic relationship between Notch and TGF-β signaling pathways in...
In a groundbreaking development that could redefine therapeutic paradigms in oncology, researchers have unveiled a novel molecular mechanism that tackles...
In a significant development poised to reshape prognostic methodologies in oncology, a new commentary published in the British Journal of...
SAN DIEGO, CA – At the forefront of cancer research and innovation, the Abramson Cancer Center (ACC) and the Perelman...
In a groundbreaking study published in Cell Death Discovery, Chen and colleagues have shed new light on the molecular mechanisms...
The International Association for Dental, Oral, and Craniofacial Research (IADR) recently unveiled the recipients of the prestigious 2026 IADR Student...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine